Thursday, April 3, 2025 4/3/2025

Kidney Health Initiative is a public-private partnership between the American Society of Nephrology, US Food and Drug Administration and the kidney community.

Award Number: R18FD005283
ORGANIZATION: FOOD AND DRUG ADMINISTRATION
OPDIV: FDA
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: KDA (KNOWLEDGE/DEVELOPMENT/APPLICATION)

Group Awards By:

View Award Description

Kidney Health Initiative is a public-private partnership between the American Society of Nephrology, US Food and Drug Administration and the kidney community. - RFA-FD-24-041 Project Summary/Abstract The Kidney Health Initiative (KHI) is a public-private partnership among the American Society of Nephrology (ASN), US Food and Drug Administration (FDA), and all major constituents in the kidney community (patients, healthcare professionals, members of industry and government). KHI is the largest consortium in the kidney community and is focused on addressing barriers to the development of new drugs, devices and biologics for people with kidney diseases. KHI’s community, governance, and infrastructure makes it uniquely positioned to convene and identify issues facing the kidney community, translate them into a pre-competitive collaborative activity, and produce a consensus deliverable. These resources provide recommendations and direction for any individual, company, or organization to use for the development of innovative kidney drugs, devices, and biologics. The current proposal builds on KHI’s accomplishments and leverages the expertise within KHI’s Board of Directors, the member community, and ASN to execute projects that include but are not limited to development and evaluation of clinical trial endpoints, creation of roadmaps to advance product development, and tools to integrate the patient perspective in clinical research and product development; convene the community to define and communicate solutions addressing shared challenges; and collaborate within and outside of the kidney community to strengthen the impact of KHI resources. Over the next five years under the direction of KHI’s Board of Directors and guidance of KHI’s Patient and Family Partnership Council, KHI will continue to advance its project portfolio and annual meeting. KHI remains a neutral and patient-centered platform that convenes the kidney community to exchange information and explore pre- competitive collaborations. To further the community’s evolution, KHI projects and annual meeting will be supplemented with increased in-depth topical activities including workshops, virtual convenings, and consistent communications with the member community. KHI will also pursue outreach opportunities to further adopt or strengthen KHI resources, support activities and projects led by strategically aligned organizations, and pursue partnerships with complementary organizations. KHI has spent a decade building an innovation community, now is the time to increase the depth of solutions that fill critical gaps impacting progress of kidney innovations.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	AMERICAN SOCIETY OF NEPHROLOGY INC	1401 H ST NW STE 900	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	001	11	3/6/2025	COMPETING CONTINUATION	$0
2025	2023	AMERICAN SOCIETY OF NEPHROLOGY INC	1401 H ST NW STE 900	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	000	10	12/4/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $300,000 )
2024	2024	AMERICAN SOCIETY OF NEPHROLOGY INC	1401 H ST NW STE 900	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	001	11	9/17/2024	COMPETING CONTINUATION	$300,000
2024	2023	AMERICAN SOCIETY OF NEPHROLOGY INC	1401 H ST NW STE 900	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	000	10	5/21/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $300,000

Issue Date FY: 2023 ( Subtotal = $300,000 )
2023	2023	AMERICAN SOCIETY OF NEPHROLOGY, INC.	1401 H ST NW STE 900	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	000	10	9/12/2023	NON-COMPETING CONTINUATION	$300,000
														Subtotal = $300,000

Issue Date FY: 2022 ( Subtotal = $168,000 )
2022	2022	AMERICAN SOCIETY OF NEPHROLOGY, INC.	1401 H ST NW STE 900	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	001	9	8/22/2022	NON-COMPETING CONTINUATION	$300,000
2022	2018	AMERICAN SOCIETY OF NEPHROLOGY, INC.	1401 H ST NW STE 900	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	000	5	7/7/2022	NON-COMPETING CONTINUATION	-$132,000
														Subtotal = $168,000

Issue Date FY: 2021 ( Subtotal = $300,000 )
2021	2021	AMERICAN SOCIETY OF NEPHROLOGY, INC.	1401 H ST NW STE 900	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	000	8	7/9/2021	NON-COMPETING CONTINUATION	$300,000
														Subtotal = $300,000

Issue Date FY: 2020 ( Subtotal = $300,000 )
2020	2020	AMERICAN SOCIETY OF NEPHROLOGY, INC.	1401 H ST NW STE 900	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	000	7	8/13/2020	NON-COMPETING CONTINUATION	$300,000
														Subtotal = $300,000

Issue Date FY: 2019 ( Subtotal = $300,000 )
2019	2019	AMERICAN SOCIETY OF NEPHROLOGY INC	1510 H ST NW	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	000	6	8/20/2019	COMPETING CONTINUATION	$300,000
														Subtotal = $300,000

Issue Date FY: 2018 ( Subtotal = $500,000 )
2018	2018	AMERICAN SOCIETY OF NEPHROLOGY INC	1510 H ST NW	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	000	5	8/8/2018	NON-COMPETING CONTINUATION	$500,000
														Subtotal = $500,000

Issue Date FY: 2017 ( Subtotal = $300,000 )
2017	2017	AMERICAN SOCIETY OF NEPHROLOGY INC	1510 H ST NW	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	000	4	8/16/2017	NON-COMPETING CONTINUATION	$500,000
2017	2017	AMERICAN SOCIETY OF NEPHROLOGY INC	1510 H ST NW	WASHINGTON	DC	20005	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	001	4	9/12/2017	NON-COMPETING CONTINUATION	-$200,000
														Subtotal = $300,000

Issue Date FY: 2016 ( Subtotal = $500,000 )
2016	2016	AMERICAN SOCIETY OF NEPHROLOGY	1725 I STREET NORTHWEST	WASHINGTON	DC	20006	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	000	3	8/8/2016	NON-COMPETING CONTINUATION	$500,000
														Subtotal = $500,000

Issue Date FY: 2015 ( Subtotal = $500,000 )
2015	2015	AMERICAN SOCIETY OF NEPHROLOGY	1725 I STREET NORTHWEST	WASHINGTON	DC	20006	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	001	2	7/29/2015	EXTENSION WITH OR WITHOUT FUNDS	$500,000
2015	2014	AMERICAN SOCIETY OF NEPHROLOGY	1725 I STREET NORTHWEST	WASHINGTON	DC	20006	DISTRICT OF COLUMBIA	USA	Food and Drug Administration Research	000	1	7/27/2015	NEW	$0
														Subtotal = $500,000

Grand Total All Awards = $3,468,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Kidney Health Initiative is a public-private partnership between the American Society of Nephrology, US Food and Drug Administration and the kidney community.

Award Number: R18FD005283

ORGANIZATION: FOOD AND DRUG ADMINISTRATION

OPDIV: FDA

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: KDA (KNOWLEDGE/DEVELOPMENT/APPLICATION)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer